Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
M. Ewen , M. Zweekhorst, B. Regeer, R. Laing (2017) Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases PLoS ONE 12(2): e0171284. doi:10.1371/journal. pone.0171284
M. Ewen, W. Kaplan, T. Gedif, M. Justin-Temu, C. Vialle-Valentin, Z. Mirza, B. Regeer, M. Zweekhorst, R. Laing Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania Journal of Pharmaceutical Policy and Practice (2017) 10: 7. doi:10.1186/s40545-016-0095-1
Ewen M, Al Sakit M, Saadeh R, Laing R, Vialle-Valentin C, Seita A, Bunders J. Comparative assessment of medicine procurement prices in the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). Journal of Pharmaceutical Policy and Practice 2014,7:13 DOI: 10.1186/2052-3211-7-13.
Bazargani YT, Ewen M, de Boer A, Leufkens HGM, Mantel-Teeuwisse AK (2014) Essential medicines are more available than other medicines around the globe. PLoS ONE 9(2): e87576. doi:10.1371/journal.pone.0087576.
Whyte P, Hall C. Review Series of Pharmaceutical Pricing Policies and Interventions: Working Paper 6: The role of health technology assessment in medicine pricing and reimbursement. WHO/HAI 2014.
Kotwani A, Holloway K. Access to antibiotics in New Delhi, India: implications for antibiotic policy Journal of Pharmaceutical Policy and Practice 2013, 6:6 doi:10.1186/2052-3211-6-6.
Medicine procurement prices and processes in the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). UNRWA 2011. Abstract published by The Lancet 8 October 2012.
Kaplan WA et al. Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010. Health Policy (2012).
Niëns LM, Van de Poel E, Cameron A, Ewen M, Laing R and Brouwer WBF (2012) Practical measurement of affordability: an application to medicines. Bulletin of the World Health Organization 2012:90:219-227.
Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HGM, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bulletin of the World Health Organization, 89(6):279-287.
Espin J. Rovera J. Review Series of Pharmaceutical Pricing Policies and Interventions: Working Paper 1: External reference pricing. WHO/HAI 2011.
Faden L, Vialle-Valentin C, Ross-Degnan D, Wagner A. Review Series on Pharmaceutical Pricing Policies and Interventions: Working Paper 2: The Role of Health Insurance in the Cost-Effective Use of Medicines. WHO/HAI 2011.
Ball, D. Review Series on Pharmaceutical Pricing Policies and Interventions: Working Paper 3: The Regulation of Mark-ups in the Pharmaceutical Supply Chain. WHO/HAI 2011.
Hawkins, L. Review Series on Pharmaceutical Pricing Policies and Interventions: Working Paper 4: Competition Policy. WHO/HAI 2011.
Creese A. Review Series on Pharmaceutical Pricing Policies and Interventions: Working Paper 5: Sales Taxes on Medicines. WHO/HAI 2011.
Niëns LM, Cameron A, Van de Poel E, Ewen M, Brouwer WBF, et al. (2010) Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World. PLoS Med 7(8): e1000333. doi:10.1371/journal.pmed.1000333.
Kotwani A. Editorial: Access to essential medicines and standard treatment for chronic diseases. Indian J Pharmacol June 2010; 42(3):127-8.
Van Mourik MSM, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data. BMC Cardiovascular Disorders 2010, 10:25doi:10.1186/1471-2261-10-25.
Madden JM, Meza E, Ewen M, Laing RO, Stephens P, Ross-Degnan D. Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology. Rev Panam Salud Publica. 2010;27(4):291-9.
Availability, price and affordability of asthma medicines in five Indian states.Int J Tub Lung Dis Vol 13, Number 5, pp. 574-579(6).
Insights for policymakers from a medicine price survey in Rajasthan. Indian J Med Res 129, pp 451-454.
Higuchi, M. Costs, availability and affordability of diabetes care in the Philippines.
Medicine prices, availability, affordability and price components: a synthesis report of medicine price surveys undertaken in selected countries of the WHO Eastern Mediterranean Region. WHO EMRO / HAI.
Volman, B. Direct costs and availability of diabetes medicines in low- and middle-income countries.
Kotwani A, Ewen M, Dey D, Iyer S et al. Prices and availability of common medicines at six sites in India using a standard methodology. Indian J Med Res 125, May 2007, pp 645-654.
Mendis S. et al (2007). The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bulletin of the World Health Organization, 85(4):279-287.
Peru Validation Study Report, WHO/HAI Project on Medicine Prices and Availability.
British Medical Journal (editorial): The great medicines scandal rapid responses to the editorial.
Conducting a Medicine Pricing Survey: Experience and Challenges. Zaheer Ud-Din Baber and Mohamed Izham Mohamed Ibrahim. Essential Drugs Monitor No. 34, 2005.
Price, availability and affordability. An international comparison of chronic disease medicines. WHO EMRO/HAI.
Surveying Medicine Situation in West Bengal – Promoting Rational Drug Use in Indonesia. This article was written by Avijit Hazra, Santanu Kumar Tripathi and Dalia Day and reports on the survey they undertook in Sept/Dec 2004.
Pharmaceutical Tariffs: What is their effect on prices, protection of local industry and revenue generation? by Müge Olcay and Richard Laing. Prepared for: The Commission on Intellectual Property Rights, Innovation and Public Health.
Nine countries from the WHO African region meet to analyse data from their Medicine Prices Surveys.